However, the extra cushioning also makes it heavier, and it doesnt include a carrying strap
These findings suggest that CagriSema could represent a highly effective therapeutic option for both weight and glycaemic management in people with Type 2 diabetes
Although the appetite-suppressing effect of semaglutide leads to weight loss, it can also cause insufficient calorie intake, which favours muscle weakness, muscle breakdown and a reduction in resilience," says sports physician Prettin, which is in line with current scientific findings, such as those of a study from 2024, which found that muscle loss caused by the GLP-1 receptor agonist was 0.8 per cent higher than that caused by the natural ageing process
How GLP-1s raise insurance premiums Premium increases vary based on whos eligible and how consistently patients stay on treatment
Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
Brown fat isnt the stuff youre trying to lose it actually burns energy to make heat